4basebio PLC (LON:4BB) Insider Heikki Lanckriet Buys 46,500 Shares

4basebio PLC (LON:4BB) insider Heikki Lanckriet acquired 46,500 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was bought at an average price of GBX 1,325 ($16.81) per share, with a total value of £616,125 ($781,884.52).

4basebio Price Performance

Shares of LON 4BB opened at GBX 1,300 ($16.50) on Wednesday. 4basebio PLC has a 1 year low of GBX 500 ($6.35) and a 1 year high of GBX 1,820 ($23.10). The stock has a market capitalization of £166.53 million, a P/E ratio of -1,666.67 and a beta of 1.09. The company’s 50-day moving average is GBX 1,344.25 and its 200 day moving average is GBX 1,411.99. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52.

About 4basebio

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines.